According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...

For her, comfort is key, and she does not mind searching through multiple shops to find the perfect frame. She believes that ...

The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.

A special needs child from HD Kote Taluk underwent successful bilateral cataract surgery, restoring sight and hope, thanks to ...

Shares in Bausch + Lomb were higher after the company received approval from the Food and Drug Administration for its enVista Envy full range of vision intraocular lens. Shares were recently up 23% at ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has ...

Bausch + Lomb said enVista Envy intraocular lenses will be commercially available in the U.S. on a limited basis in the coming weeks and more broadly in 2025. The company is in the process of seeking ...

Yet, often overlooked in the broader healthcare conversation is the crucial role of eye care. Vision impairment and blindness affect millions of Nigerians, yet primary eye care remains underdeveloped ...

Its growth is attributed to a trend towards medical tourism for low-cost procedures. The global ophthalmology devices market ...

The approval comes amidst rumours of a potential private equity buyout of the Canadian company, whose parent company has ...

It was quite a busy and eventful day for the company.